Cargando…

BMP9 Morphs into a Potential Player in Portopulmonary Hypertension

Detalles Bibliográficos
Autor principal:	Toshner, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444656/ https://www.ncbi.nlm.nih.gov/pubmed/30383395 http://dx.doi.org/10.1164/rccm.201810-1886ED

Ejemplares similares

Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010)

Portopulmonary Hypertension: An Updated Review
por: Jasso-Baltazar, Erick A., et al.
Publicado: (2023)

Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020)

Causes and Circumstances of Death in Portopulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

Portopulmonary hypertension: Success with combined medical treatment
por: Hernández, María, et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension
por: Saleemi, Sarfraz, et al.
Publicado: (2014)

Portopulmonary hypertension in children: a rare but potentially lethal and under-recognized disease
por: Tingo, Jennifer, et al.
Publicado: (2017)

The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
por: Takahashi, Yukiko, et al.
Publicado: (2021)

Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023)

Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan
por: Tokushige, Katsutoshi, et al.
Publicado: (2023)

Portopulmonary hypertension caused by portal hypertension that is complicated by central diabetes insipidus
por: Zhao, Tingting, et al.
Publicado: (2020)

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes
por: DuBrock, Hilary M., et al.
Publicado: (2019)

The early outcomes of candidates with portopulmonary hypertension after liver transplantation
por: Huang, Bingsong, et al.
Publicado: (2018)

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients
por: Li, Jian, et al.
Publicado: (2018)

Possible use of pulmonary artery stiffness in screening for portopulmonary hypertension
por: Wessels, Jeroen N., et al.
Publicado: (2022)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

Left main coronary artery compression in a patient with portopulmonary hypertension
por: de Araújo, Iara Teixeira, et al.
Publicado: (2018)

Living donor liver transplantation in a patient with severe portopulmonary hypertension
por: Singh, Shweta A, et al.
Publicado: (2020)

Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors
por: CHEN, HUI-SONG, et al.
Publicado: (2013)

Venous outflow obstruction and portopulmonary hypertension after orthotopic liver transplantation
por: Aguirre-Avalos, Guadalupe, et al.
Publicado: (2013)

Sarcoidosis-induced pericarditis in a patient with portopulmonary hypertension: a case report
por: Giouleme, Olga, et al.
Publicado: (2009)

Liver transplantation for severe portopulmonary hypertension: A case report and literature review
por: Chen, Xiao-Jie, et al.
Publicado: (2019)

Management of acute subdural hematoma in a patient with portopulmonary hypertension on prostanoid therapy
por: Rammo, Richard, et al.
Publicado: (2017)

Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan
por: Atsukawa, Masanori, et al.
Publicado: (2022)

Congenital portopulmonary shunt in a cat
por: Terai, K., et al.
Publicado: (2022)

Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study
por: Shao, Yueming, et al.
Publicado: (2021)

Natural killer cell-mediated immune deficiency or compromise in patients with portopulmonary hypertension
por: Chen, Huisong, et al.
Publicado: (2014)

Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
por: Türker, Fatih, et al.
Publicado: (2022)

Prevalence and Clinical Features of Portopulmonary Hypertension in Patients With Hepatic Cirrhosis: An Echocardiographic Study
por: Gupta, Anany, et al.
Publicado: (2022)

Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry
por: Tamura, Yudai, et al.
Publicado: (2022)

Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
por: Zopey, Radhika, et al.
Publicado: (2013)

Aggravation of Hepatopulmonary Syndrome after Sildenafil Treatment in a Patient with Coexisting Portopulmonary Hypertension
por: Chung, Seungmin, et al.
Publicado: (2015)

Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis
por: Yin, Xin, et al.
Publicado: (2020)

Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review
por: Li, Niuniu, et al.
Publicado: (2023)

Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates
por: Hayashi, Ryoko, et al.
Publicado: (2022)

Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes
por: del Valle, Kathryn T., et al.
Publicado: (2022)

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease
por: Wakabayashi, Shun‐Ichi, et al.
Publicado: (2023)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry
por: DuBrock, Hilary M., et al.
Publicado: (2021)

Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies
por: Cartin-Ceba, Rodrigo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jlsbn14ho3toan90hkcloku8ls